Citigroup Inc Medicinova Inc Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Medicinova Inc stock. As of the latest transaction made, Citigroup Inc holds 447,957 shares of MNOV stock, worth $645,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares

447,957

Previous 447,957 -0.0%

Holding current value

$645,058

Previous $671,000 3.28%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$2.01 - $2.6 $101,102 - $130,780	-50,300 Reduced 10.1%	447,957 $936,000
Q2 2023 Aug 10, 2023	BUY	$2.09 - $2.43 $105,127 - $122,229	50,300 Added 11.23%	498,257 $1.15 Million
Q4 2022 Feb 09, 2023	SELL	$1.97 - $2.66 $4,462 - $6,024	-2,265 Reduced 0.5%	447,957 $918,000
Q3 2022 Nov 10, 2022	BUY	$2.1 - $2.6 $4,756 - $5,889	2,265 Added 0.51%	450,222 $977,000
Q4 2021 Feb 10, 2022	SELL	$2.61 - $4.42 $6,511 - $11,027	-2,495 Reduced 0.55%	447,957 $1.2 Million

Q3 2021 Nov 10, 2021	BUY	$3.4 - $4.24 $1.53 Million - $1.91 Million	450,452 New	450,452 $1.71 Million

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.58M

Call Options Held

12.5K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $70.6M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account